Early test: can a new drug calm nerves and lower blood pressure in obesity?
NCT ID NCT06482853
Summary
This early-stage study aims to understand if an experimental drug called angiotensin-(1-7) can improve heart and blood vessel health in people who have both obesity and high blood pressure. Researchers will give the drug or a placebo (saltwater) to 52 participants through an IV and carefully measure its effects on nerve activity, blood pressure, and blood vessel function. The goal is to gather knowledge about how this drug works, not to provide a treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Penn State Milton S. Hershey Medical Center
RECRUITINGHershey, Pennsylvania, 17033, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.